New Price Target For AFFY

October 4, 2010 9:50 AM | 7 seconds read | Make a Comment

Argus reiterates its Buy rating for Affymax Inc.

AFFY

but has lowered the price target from $30 to $15.

Posted In: Price Target Initiation Analyst Ratings affymax Argus Biotechnology Health Care

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.